Printer Friendly

Browse Drug delivery systems topic

Planning subtopic

Articles

1-19 out of 19 article(s)
Title Author Type Date Words
Becton, Dickinson and Company announces USD1.2bn investment to expand pre-fillable syringe manufacturing capacity. Dec 2, 2020 190
Becton, Dickinson and Company announces USD1.2bn investment to expand pre-fillable syringe manufacturing capacity. Dec 2, 2020 186
Horizon Therapeutics, Halozyme Therapeutics Enter Global Collaboration and License Agreement for Enhanze Technology. Nov 25, 2020 416
Lexaria Bioscience widens scope of pharmaceutical subsidiary in bid to develop treatment for coronavirus. Mar 24, 2020 521
Lexaria Bioscience planning to list on a major US exchange in 2020, says CEO. Jan 10, 2020 575
Veru adds VERU-100 to prostate cancer drug development pipeline. Jun 4, 2019 177
Deerfield provides USD 125m to Tris Pharm as growth capital. Oct 12, 2018 128
Deerfield provides USD 125m to Tris Pharm as growth capital. Oct 12, 2018 126
Eli Lilly and Company plans to build new drug delivery and device innovation centre in Massachusetts. May 8, 2015 165
Eli Lilly and Company plans to build new drug delivery and device innovation centre in Massachusetts. May 8, 2015 161
Depomed Inc plans to file NDA with US FDA for Serada for menopausal hot flashes. Apr 18, 2012 198
Pfizer stops Phase III Sutent trial: GSK, Genmab refocus ofatumumab program. Oct 1, 2010 1642
CEO INTERVIEW: MICHAEL ASHTON - SKYEPHARMA PLC (SKYE). Brief Article May 29, 2003 89
CEO INTERVIEW: TOD HAMACHEK - PENWEST PHARMACEUTICALS INC (PPCO). Brief Article May 29, 2003 90
CEO INTERVIEW: ROGER HARRISON - ANTARES PHARMA INC (ANTR). Brief Article May 29, 2003 90
CEO INTERVIEW: MICHAEL GOLDBERG - EMISPHERE TECHNOLOGIES (EMIS). Brief Article May 29, 2003 89
CEO INTERVIEW: CHRISTOPHER SEARCY - NEKTAR THERAPEUTICS (NKTR). Brief Article May 29, 2003 89
CEO INTERVIEW: KEN HOWLING - BIOVAIL CORPORATION (BVF). Brief Article May 29, 2003 89
CEO INTERVIEW: JAMES BROWN - DURECT CORPORATION (DRRX). Brief Article May 29, 2003 89

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |